Literature DB >> 27430206

High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma.

Roberto Paradisi1, Rossella Vicenti1, Maria Macciocca2, Renato Seracchioli1, Stefania Rossi1, Raffaella Fabbri1.   

Abstract

OBJECTIVE: To investigate the ovarian reserve in female lymphoma patients and the potential relationships with the cytokine network.
DESIGN: Age-matched control study.
SETTING: Women's university hospital. PATIENT(S): Seventy-three lymphoma patients (57 with classic Hodgkin lymphoma [HL] and 16 with non-Hodgkin lymphoma [NHL]), approaching our center for ovarian tissue cryopreservation (study group) were compared with 25 age-matched healthy volunteers (control group). INTERVENTION(S): Measurements of antimüllerian hormone (AMH), soluble interleukin-2 receptor (SIL-2R), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor α (TNF-α) levels. MAIN OUTCOME MEASURE(S): The AMH and cytokine levels of the lymphoma patients and the healthy volunteers were compared. Correlations between AMH with SIL-2R, IL-6, and IL-8 levels were performed. RESULT(S): The AMH showed significant lower concentrations in lymphoma patients than in the control group. Higher significant concentrations in lymphoma patients than in control group were found for SIL-2R and IL-6. No differences were observed comparing HL and NHL groups and within the stages of HL group for AMH and all the cytokines analyzed. Finally, significant inverse correlations were observed in lymphoma patients between AMH and SIL-2R, IL-6, and IL-8 levels, but not with TNF-α levels. Positive correlations between SIL-2R with IL-6, and IL-6 with IL-8 were also shown. CONCLUSION(S): In patients with HL or NHL at baseline the cytokine network is particularly active and the ovarian reserve is reduced. A strong negative correlation between AMH and SIL-2R, IL-6, and IL-8 has been also evidenced.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimüllerian hormone; Hodgkin lymphoma. non-Hodgkin lymphoma; cytokines; fertility preservation

Mesh:

Substances:

Year:  2016        PMID: 27430206     DOI: 10.1016/j.fertnstert.2016.06.035

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  The Effects of Negative Elements in Environment and Cancer on Female Reproductive System.

Authors:  Jiangxue Qu; Yuehan Li; Shujie Liao; Jie Yan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder.

Authors:  Jan Thöne; Solveig Lichtenberg; Anna Stahl; Florence Pache; Ingo Kleiter; Klemens Ruprecht; Ralf Gold; Kerstin Hellwig
Journal:  Front Neurol       Date:  2018-06-19       Impact factor: 4.003

3.  Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes.

Authors:  Catherine Kim; Yuanyuan Pan; Barbara H Braffett; Valerie L Arends; Michael W Steffes; Hunter Wessells; Aruna V Sarma
Journal:  Womens Midlife Health       Date:  2017-08-18

4.  Integrated analysis of 14 lymphoma datasets revealed high expression of CXCL14 promotes cell migration in mantle cell lymphoma.

Authors:  Dahai Liu; Fei Qi; Wei Liu; Justin Liu; Jun Wang; Dao-Qiang Lu; Yang Xun; Min-Min Chen; Xin Chen; Shu-Ting Yang; Wen-Qiao Jiao; Zong-Ye Li; Fang Liu; Hua Yang; Wen-Xing Li
Journal:  Aging (Albany NY)       Date:  2022-04-22       Impact factor: 5.682

5.  Anti-Mullerian hormone levels in female cancer patients of reproductive age in Indonesia: A cross-sectional study.

Authors:  Achmad Kemal Harzif; Budi Wiweko; Putri Addina; Kartika Iswaranti; Melisa Silvia; Ana Mariana; Kresna Mutia; Kanadi Sumapraja; R Muharam; Gita Pratama
Journal:  F1000Res       Date:  2019-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.